In the final episode of the short series, Akhila Kosaraju, MD, talks about changing the development paradigm and moving away from reengineering molecules of existing antibiotic classes and towards creating new ones. #IDsky #Medtsky
www.contagionlive.com/view/it-s-ti...
0
1
0
2
